Insider tradingForm 4

Iambic Therapeutics, Inc. (IAM) Insider Trading

1 open-market trades reported since Oct 19, 2026: 1 purchases worth $11.5M and 0 sales worth $0.

By insider

Insider	Role	Buys	Bought	Sells	Sold	Latest
Evan Lockwood Rachlin	Director	1	$11.5M	0	$0	Oct 19, 2026

IAM insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	3 mo. after	Filing
Oct 19	Oct 16	Evan Lockwood RachlinDirector	Director (ind.)	▲ BUY	718,750	16.00	$11.5M	+38%		Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings